3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Carcinoma, Ovarian Epithelial
5
Ovarian Neoplasms
4
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Sarcoma, Endometrial Stromal
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rhabdomyosarcoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibrosarcoma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Interventions
pembrolizumab
5
Carboplatin
4
Nivolumab
3
Cisplatin
3
durvalumab
2
Paclitaxel
2
Immunohistochemistry
2
Fluorouracil
2
Bevacizumab
2
tremelimumab
1
toripalimab
1
regorafenib
1
obinutuzumab
1
naptumomab estafenatox
1
liposomal doxorubicin
1
enzalutamide
1
aflibercept
1
abiraterone
1
abemaciclib
1
Ritonavir
1
Polymerase Chain Reaction
1
Oxaliplatin
1
NEO212
1
Mass Spectrometry
1
Lopinavir
1
Leucovorin
1
Itraconazole
1
Isotretinoin
1
Ipilimumab
1
Interferon-alpha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Mass Spectrometry
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled